U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07040917) titled 'A Study of CAR-T Cells in Subjects With Autoimmune Diseases' on June 18.
Brief Summary: The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with autoimmune diseases.
Study Start Date: June 30
Study Type: INTERVENTIONAL
Condition:
Autoimmune Diseases
Intervention:
DRUG: CAR-T cell
CAR-T cell
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Chinese PLA General Hospital
Information provided by (Responsible Party): Jian Zhu, Chinese PLA General Hospital
Published by HT Digital Content Services with permission from Health Daily Digest....